Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Medtronic plc (MDT)
Market Closed
15 Oct, 08:00 PM
NYSE
All
(14)
DE
(6)
AT
(1)
CH
(2)
MX
(1)
IT
(2)
GB
(1)
US
(1)
NYSE
Primary
LSE
XDUS
XSTU
XHAN
XMUN
XETRA
XFRA
XMIL
XMEX
XWBO
XMIL
SIX
SIX
$
95.
45
+1.22
+1.2947%
$
122.1B
Market Cap
25.14
P/E Ratio
2.84%
Div Yield
50.23M
Volume
5.2
Eps
$
94.23
Previous Close
Investors:
TJD
DI
LC
+624
Watching
Watch
Add Transaction
Day Range
93.96
96.24
Year Range
73.31
106.33
Want to track
MDT
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
Medtronic plc (MDT) Statistics
Valuation metrics
Market Cap
122.1B
Enterprise value
139.72B
Trailing P/E (ttm)
21.63
Forward P/E
14.3
PEG ratio
1.71
Price/Sales (ttm)
3.02
Price/Book (mrq)
2.25
Enterprise Value/Revenue
3.72
Enterprise Value/EBITDA
13.73
Overview
Shares outstanding
1.28B
Float
1.28B
Shares short
15.43M
% Held by insiders
0%
% Held by institutions
0.88%
Average volume (10 days)
31.58M
Average volume (90 days)
10.68M
Price summary
52-Week low
73.31
52-Week high
106.33
Beta
0.73
50-Day moving average
90.09
200-Day moving average
83.1
Dividends and splits
Forward annual dividend rate
2.84
Forward annual dividend yield
0.0326%
Trailing annual dividend rate
2.86
Trailing annual dividend yield
0.0323%
5-Year annual dividend yield
2.92%
Payout ratio
0.7
Dividend Date
16 Oct 2026
Ex-Dividend Date
25 Sep 2026
Last split factor
2:1
Last split Date
27 Sep 1999
Financials
Fiscal year
Fiscal year ends
25 Apr 2025
Most recent quarter (mrq)
31 Jan 2026
Profitability
Profit margin
0.14%
Operating margin
0.18%
Operational effectiveness
Return on assets
0.06%
Return on equity
0.11%
Income Statement
Revenue (ttm)
35.48B
Revenue per share (ttm)
29.33
Quarterly revenue growth (yoy)
0.09%
Gross profit (ttm)
23.12B
EBITDA
9.94B
Net income to common (ttm)
4.61B
Diluted EPS (ttm)
4.09
Quarterly earnings growth (yoy)
-0.12%
Balance Sheet
Total cash (mrq)
8.38B
Total cash per share (mrq)
6.89
Total debt (mrq)
28.07B
Total Debt/Equity (mrq)
0.56
Current ratio (mrq)
2.07%
Book value per share (mrq)
39.73
Cash Flow
Cash flow statement
7.29B
Levered free cash flow (LFCF)
4.07B